Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cognitive Impairment Characteristics and Biological Mechanisms in Untreated Severe Mental Illness

NCT07448675 is registered in ClinicalTrials.gov with Tianjin Anding Hospital as lead sponsor.

NCT NCT07448675
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07448675 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cognitive Impairment Characteristics and Biological Mechanisms in Untreated Severe Mental Illness
Lead sponsor
Tianjin Anding Hospital
Phase
Observational
Overall status
Enrolling by invitation
Start date
February 7, 2023
Completion date
June 30, 2026
Enrollment
230 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

patients with severe mental illness